Biliary Glutathione as a Potential Marker for Viability Assessment of Cholangiocytes During Normothermic Machine Perfusion of Livers
Artificial Organs · 2026
DOI: 10.1111/aor.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2026. Verfasst von Christina Bogensperger und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Transplant and Thoracic Surgery, organLife Organ Regeneration Center of Excellence, and Daniel Swarovski Research Laboratory,…. Hauptthemen laut MEDLINE: Glutathione, Liver Transplantation, Perfusion, Bile. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical University of Innsbruck, Medizinische Universität Innsbruck.
Abstract (Originalsprache)
Background
Normothermic machine perfusion (NMP) is increasingly used to assess liver grafts before transplantation. While viability assessment of the hepatocellular compartment has been widely adopted, viability assessment of the biliary compartment remains controversial due to the lack of reliable markers. Glutathione (GSH) plays a key role in bile formation and may serve as a marker for biliary viability. Thus, the present study aimed to investigate the suitability of GSH as a potential marker for biliary viability assessment during NMP.
Methods
Between 2018 and 2021, livers undergoing NMP were included in the study. Bile samples were collected at 1 h, 6 h, and at the end of NMP, and then analyzed using enzyme‐linked immunosorbent assay (ELISA). Results were correlated with perfusion parameters and clinical outcomes.
Results
56 livers underwent NMP during the study period, of which 41 were successfully transplanted (73.2%). Within 1 year after transplantation, 19 patients (46.3%) developed biliary complications. 1‐year patient survival was 80.5% and 1‐year graft survival (death‐censored) was 94.6%. The GSH in transplanted livers showed a significant increase over time (Hour 1: 25.9 ± 31.2 μM vs. End: 108.7 ± 95.3 μM, p < 0.001) and significant inverse correlation with the occurrence of biliary complications after transplantation ( p < 0.05). GSH concentration at the first hour measurement was significantly lower in livers that were deemed non‐transplantable (11.2 μM vs. 25.9 μM, p = 0.006).
Conclusions
Our data show an increase of GSH in bile during liver ex situ NMP. We found a negative correlation between GSH concentration and the development of biliary complications, suggesting GSH as a new marker for biliary viability assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Visceral, Transplant and Thoracic Surgery, organLife Organ Regeneration Center of Excellence, and Daniel Swarovski Research Laboratory, Medical University of Innsbruck, Innsbruck, Austria.
ORCID-Profile: Christina Bogensperger, Florian Ponholzer, Annemarie Weissenbacher
Förderung
- Medical University of Innsbruck
- Medizinische Universität Innsbruck
Zitieren
APA
Bogensperger, C., Esser, H., Ponholzer, F., Cardini, B., Hofmann, J., Messner, F., Oberhuber, R., Resch, T., Öfner, D., Schneeberger, S., & Weissenbacher, A. (2026). Biliary Glutathione as a Potential Marker for Viability Assessment of Cholangiocytes During Normothermic Machine Perfusion of Livers. Artificial Organs. https://doi.org/10.1111/aor.70024
Vancouver
Bogensperger C, Esser H, Ponholzer F, Cardini B, Hofmann J, Messner F, et al. Biliary Glutathione as a Potential Marker for Viability Assessment of Cholangiocytes During Normothermic Machine Perfusion of Livers. Artificial Organs. 2026. doi:10.1111/aor.70024
BibTeX
@article{Bogensperger2026,
author = {Bogensperger, Christina and Esser, Hannah and Ponholzer, Florian and Cardini, Benno and Hofmann, Julia and Messner, Franka and Oberhuber, Rupert and Resch, Thomas and Öfner, Dietmar and Schneeberger, Stefan and Weissenbacher, Annemarie},
title = {Biliary Glutathione as a Potential Marker for Viability Assessment of Cholangiocytes During Normothermic Machine Perfusion of Livers},
journal = {Artificial Organs},
year = {2026},
doi = {10.1111/aor.70024}
}
EUVIMED